SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Israeli startups raised $1.5 billion in July as investors doubled down on enterprise AI

Why Israel may need to take its most secret missile maker public

Another 10 U.S. tankers are headed to Israel's Ben Gurion as airport delays mount

OpenAI uncovers more rogue AI incidents as scrutiny of frontier models intensifies

Buzz

Most popular

Daily

Weekly

1

Israel searches for technology that could find soldiers and pilots who cannot call for help

2

Another 10 U.S. tankers are headed to Israel's Ben Gurion as airport delays mount

3

After IAI and Rafael, secretive missile engine maker Tomer moves toward an IPO

4

ServiceNow continues layoffs as it restructures around AI

5

Israel's Iron Dome and Arrow makers unlikely to reach the IPO market before 2027 as Tomer joins the queue

Blood Cancer

4 stories about Blood Cancer

אחות אחיות רפואה סיעוד

Novartis Invests $10 Million in Anti-Cancer Company Ayala Pharmaceuticals

24.12.18|Lilach Baumer

The investment is part of a licensing option agreement signed between the two companies

פרופסור זליג אשחר

Scientist’s Ex-Wife Joins Legal Melee Over Kite Pharma Windfall

16.01.18|Zohar Shahar Levy

Zelig Eshhar, the patent holder for Kite Pharma’s anti-cancer technology, is currently being sued by a former student for infringement of patent rights

המדען הראשי ב כלל ביוטכנולוגיה ד"ר ג'וליאן אדמס

Pharma Veteran Julian Adams takes Helm at Gamida Cell

21.11.17|Lilach Baumer

The Novartis-backed company is developing a universal bone marrow transplant solution for patients unable to find a donor

Kite Pharma’s Cancer Drug Gets Regulatory Nod

19.10.17|Lilach Baumer

The cancer-treatment company, bought by Gilead Science in August for $11.9 billion, will sell one treatment course of the drug for $373,000